NEW YORK (GenomeWeb News) – PerkinElmer reduced its workforce by 437 people in 2012, it said in its Form 10-K filed with the US Securities and Exchange Commission this week.

The layoffs resulted from efforts by the company to shift resources to higher growth geographic regions and end markets, as well as a shift of certain operations into a new shared service center, and a realignment of operations, R&D, and production resources, it said.

As a result of the layoffs, PerkinElmer took restructuring charges totaling $24.4 million related to severance payments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times' George Johnson muses on cancer's roots in multicellularity.

The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.

Jun Wang, the chief executive of BGI, has stepped down.

In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.